Negotiations over Sputnik, Sinovac vaccines at an advanced stage – deputy president
Deputy President David Mabuza has said negotiations with the manufacturers of the Sputnik and Sinovac Covid-19 vaccines are at an advanced stage.
"Further interventions being implemented to save lives are ongoing negotiations with vaccine manufacturers such as Gamaleya Institute for the Sputnik V and manufacturers of Sinovac that are at an advanced stage," he said in response to oral questions in the National Council of Provinces (NCOP).
The deputy president dealt with the mass vaccination programme, which he described as a "major response area" in saving lives and achieving population health.
"Initially, there was a slow uptake to vaccinations due to limited supply of vaccines as a result of global demand for vaccination, as well as pessimism towards their use.
"This has been addressed by concluding negotiations with manufacturers and upscaling government risk communications," he said.
Mabuza said regulatory issues had also impacted the scale and pace of the vaccination programme.
"Notwithstanding these challenges, we are forging ahead, and the vaccination acquisition and distribution to provinces has also improved, hence we are witnessing the rise in the number of those being vaccinated," he said.
The deputy president further stated that government was also enhancing local manufacturing capability through collaboration with partners within Brics, which will "enable us to overcome the current pandemic and respond to future health emergencies".
"As government, we will continue to ensure that every citizen enjoys the rights to life, equality and human dignity as outlined in the Bill of Rights with the recent surge of new cases.
"We want to appeal to all of us to continue to observe Covid-19 protocols to curb further infections while working on achieving population immunity through vaccines," Mabuza said.
On Tuesday, President Cyril Ramaphosa announced that the country was officially in the third wave of the pandemic.
He moved the country to lockdown Level 3 and said South Africa had recorded an average of 7 500 daily infections over the preceding seven days, News24 reported.
Article Enquiry
Email Article
Save Article
Feedback
To advertise email advertising@creamermedia.co.za or click here
Press Office
Announcements
What's On
Subscribe to improve your user experience...
Option 1 (equivalent of R125 a month):
Receive a weekly copy of Creamer Media's Engineering News & Mining Weekly magazine
(print copy for those in South Africa and e-magazine for those outside of South Africa)
Receive daily email newsletters
Access to full search results
Access archive of magazine back copies
Access to Projects in Progress
Access to ONE Research Report of your choice in PDF format
Option 2 (equivalent of R375 a month):
All benefits from Option 1
PLUS
Access to Creamer Media's Research Channel Africa for ALL Research Reports, in PDF format, on various industrial and mining sectors
including Electricity; Water; Energy Transition; Hydrogen; Roads, Rail and Ports; Coal; Gold; Platinum; Battery Metals; etc.
Already a subscriber?
Forgotten your password?
Receive weekly copy of Creamer Media's Engineering News & Mining Weekly magazine (print copy for those in South Africa and e-magazine for those outside of South Africa)
➕
Recieve daily email newsletters
➕
Access to full search results
➕
Access archive of magazine back copies
➕
Access to Projects in Progress
➕
Access to ONE Research Report of your choice in PDF format
RESEARCH CHANNEL AFRICA
R4500 (equivalent of R375 a month)
SUBSCRIBEAll benefits from Option 1
➕
Access to Creamer Media's Research Channel Africa for ALL Research Reports on various industrial and mining sectors, in PDF format, including on:
Electricity
➕
Water
➕
Energy Transition
➕
Hydrogen
➕
Roads, Rail and Ports
➕
Coal
➕
Gold
➕
Platinum
➕
Battery Metals
➕
etc.
Receive all benefits from Option 1 or Option 2 delivered to numerous people at your company
➕
Multiple User names and Passwords for simultaneous log-ins
➕
Intranet integration access to all in your organisation
















